Suppr超能文献

人氨肽酶A的酶学性质。钙和血管紧张素IV对其酶活性的调节。

Enzymatic properties of human aminopeptidase A. Regulation of its enzymatic activity by calcium and angiotensin IV.

作者信息

Goto Yoshikuni, Hattori Akira, Ishii Yasuhiro, Mizutani Shigehiko, Tsujimoto Masafumi

机构信息

Laboratory of Cellular Biochemistry, RIKEN, Wako, Saitama, 351-0198, Japan.

出版信息

J Biol Chem. 2006 Aug 18;281(33):23503-13. doi: 10.1074/jbc.M603191200. Epub 2006 Jun 21.

Abstract

Aminopeptidase A (APA) is a type II membrane-bound protein implicated in the regulation of blood pressure in the brain renin-angiotensin system. In this study, a recombinant soluble form of APA was expressed in a baculovirus system, purified to homogeneity, and characterized. By using synthetic substrates, it was shown that although the enzyme has a rather broad substrate specificity in the absence of Ca2+, the preferential release of acidic amino acid residues was observed in the presence of Ca2+. Moreover, Ca2+ up- or down-regulated the enzymatic activity depending on the substrate. By searching for natural substrates of APA, we found that peptides having acidic amino acids at their N terminus (angiotensin II, neurokinin B, cholecystokinin-8, and chromogranin A) were cleaved by the enzyme efficiently in the presence but not in the absence of Ca2+. Moreover kallidin (Lys-bradykinin) was converted to bradykinin effectively only in the absence of Ca2+. These results suggest that Ca2+ increases the preference of the enzyme for the peptide substrates having N-terminal acidic amino acids. In addition, we found that angiotensin IV could bind to APA both in the presence and absence of Ca2+ and inhibited the enzymatic activity of APA competitively, suggesting that angiotensin IV acts as a negative regulator of the enzyme once generated from angiotensin II by the serial actions of aminopeptidases. Taken together, these results suggest that there exists a complex regulation of the enzymatic activity of APA, which may contribute to homeostasis such as regulation of blood pressure, maintenance of memory, and normal pregnancy by controlling the concentrations of peptide substrates.

摘要

氨肽酶A(APA)是一种II型膜结合蛋白,参与脑肾素-血管紧张素系统中的血压调节。在本研究中,一种重组可溶性形式的APA在杆状病毒系统中表达,纯化至同质,并进行了特性鉴定。通过使用合成底物表明,尽管该酶在没有Ca2+的情况下具有相当广泛的底物特异性,但在有Ca2+存在时观察到酸性氨基酸残基的优先释放。此外,Ca2+根据底物上调或下调酶活性。通过寻找APA的天然底物,我们发现N端具有酸性氨基酸的肽(血管紧张素II、神经激肽B、胆囊收缩素-8和嗜铬粒蛋白A)在有Ca2+存在而非不存在时被该酶有效切割。此外,激肽释放酶原(赖氨酸缓激肽)仅在没有Ca2+时有效地转化为缓激肽。这些结果表明,Ca2+增加了该酶对具有N端酸性氨基酸的肽底物的偏好性。此外,我们发现血管紧张素IV在有和没有Ca2+的情况下都能与APA结合,并竞争性抑制APA的酶活性,这表明血管紧张素IV一旦通过氨肽酶的系列作用从血管紧张素II产生,就作为该酶的负调节剂。综上所述,这些结果表明存在对APA酶活性的复杂调节,这可能通过控制肽底物的浓度有助于体内稳态,如血压调节、记忆维持和正常妊娠。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验